Learn more about our projects below.
Active Projects

A Noninvasive, AI-Powered, Low-Cost Urine Biomarker Test for Early Detection of Breast Cancer: A Validation Study
Our team is evaluating a noninvasive urine‑based screening approach that uses electronic nose (eNose) technology and artificial intelligence to detect biochemical patterns associated with breast cancer. This research aims to address limitations of mammography, particularly in women with dense breast tissue, where cancer detection can be more challenging.
The study is being conducted at Moffitt Cancer Center and in partnership with Moffitt‑affiliated 3D Mobile Mammography outreach events, allowing participation in both clinical and community settings. This work is supported by the Florida Department of Health through the Florida Innovation Award. Findings from this study will help inform future efforts to develop accessible, low‑cost tools that could complement mammography and improve early breast cancer detection.
STAND: Stigma, Treatment, and Access in Navigating Dual HIV and Cancer Care
The STAND Study seeks to understand how experiences of stigma affect healthcare access, treatment, and survivorship among people living with HIV and cancer. By combining patient surveys, interviews, and real-world clinical data, the study explores barriers and facilitators to receiving high-quality care across healthcare settings.
Working in collaboration with community partners across Florida, our goal is to identify actionable strategies that reduce stigma, improve care experiences, and support better health outcomes for people navigating both HIV and cancer.

The REACH Study seeks to understand how people living with HIV access and experience lung cancer screening. By combining electronic health record data, surveys, and patient interviews, the study examines patterns of lung cancer screening use, follow-up care, and the social and healthcare factors that influence screening participation among people with HIV.
Working in partnership with community organizations and healthcare systems across Florida, our goal is to identify barriers and opportunities to improve equitable access to life-saving lung cancer screening. Findings from this study will help inform future interventions and screening strategies aimed at reducing lung cancer disparities among people living with HIV.
The Support Through Remote Observation and Nutrition Guidance (STRONG) intervention
Our study team developed the Support Through Remote Observation and Nutrition Guidance (STRONG) intervention which aims to reduce malnutrition and improve quality of life among cancer patients. The multi-level intervention includes system-level (e.g., routine malnutrition and screening), provider-level (e.g., dietitian training and web-based dashboard), and patient-level strategies (e.g., individualized nutrition plan, self-monitoring of dietary intake via Fitbit, ongoing goal monitoring and feedback). The intervention is being evaluated through several ongoing studies including individuals with pancreatic cancer, individuals with gastroesophageal cancer, individuals receiving cytoreductive surgery and heated intra-peritoneal chemotherapy (CRS-HIPEC), and individuals receiving pancreatectomy surgery. STRONG intervention development and pilot testing has been funded grants from the Pancreatic Cancer Action Network Alliance, the Department of Defense, and Moffitt Cancer Center.
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
Our team is partnering with Osara Health to pilot test a digital coaching intervention for pancreatic cancer patients and their caregivers (N= 10 patient-caregiver dyads). The 6-week intervention will provide patients with coaching services to navigate common issues encountered during cancer care including symptom management, nutrition, exercise, and stress management. Caregivers will receive coaching services to navigate common issues associated with cancer caregiving including healthcare system navigation, the practical aspects of caregiving, communication, and self-care. The primary aim of the study is to assess the feasibility, acceptability, and usability of digital coaching for pancreatic cancer patients and their caregivers.
Developing an embedded palliative clinic model to expand early access to palliative care for pancreatic cancer patients
Our team recently received funding from the Canopy Cancer Collective to pilot test an embedded palliative care model within the gastrointestinal oncology clinic to improve the timeliness of palliative care receipt among patients with advanced pancreatic cancer (N= 50). The goal of this pilot study is to assess the feasibility and acceptability of the embedded palliative clinic model as an implementation strategy for increasing access to early palliative care among pancreatic cancer patients.
Completed Projects
Disparities in treatment patterns and outcomes among endometrial cancer patients
Our team received funding from Flatiron Health to evaluate racial and ethnic disparities in treatment patterns including end-of-life care and supportive care access for endometrial cancer patients. The study will also explore disparities in treatment patterns based on health insurance coverage. The project leverages Flatiron Health database which collects real-world clinical data from oncology patients in academic and community settings.
Disparities in cancer treatment delays during the COVID-19 pandemic
Our team recently received funding from the ASCO Foundation, Conquer Cancer®, to evaluate disparities in cancer care and treatment disruption during the COVID-19 pandemic. The project leverages ASCO registry data to explore how cancer care delivery was affected nationally during the pandemic.
Digital therapeutic for cancer symptom management among head and neck cancer patients
Our team is partnering with Aptar digital health to pilot test a digital therapeutic for cancer symptom management among head and neck cancer patients receiving chemoradiation (N=20 patients). The 90-day intervention will provide cancer patients with a mobile app to report symptoms and receive feedback in real-time on how to manage low-grade symptoms. High-grade symptoms reported will be addressed by clinic teams who will have access to a provider portal for symptom monitoring. The primary aim of the study is to assess the feasibility, acceptability, and usability of the digital therapeutic for head and neck cancer patients.
